Cargando…
Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020
BACKGROUND: A pillar of the United States’ Ending the HIV Epidemic (EHE) initiative is to rapidly provide antiretroviral therapy (ART) in order to achieve HIV viral suppression. However, insurance benefit design can impede ART access. The primary objective of this study is to understand how Affordab...
Autores principales: | Khazanchi, Rohan, Powers, Samuel, Killelea, Amy, Strumpf, Andrew, Horn, Tim, Hamp, Auntré, McManus, Kathleen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116786/ https://www.ncbi.nlm.nih.gov/pubmed/37081570 http://dx.doi.org/10.1186/s40545-023-00559-8 |
Ejemplares similares
-
870. Coverage, Cost Sharing, and Out-of-Pocket Costs for Single-Tablet HIV Antiretroviral Regimens in Qualified Health Plans in the United States, 2018-2020
por: Khazanchi, Rohan, et al.
Publicado: (2021) -
Economic benefits of the United States’ AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities
por: McManus, Kathleen A., et al.
Publicado: (2022) -
Ryan White HIV/AIDS Part B and AIDS Drug Assistance Programs during COVID-19: safety net public health programs’ challenges and innovations
por: McManus, Kathleen A., et al.
Publicado: (2023) -
Twitter Sentiment Predicts Affordable Care Act Marketplace Enrollment
por: Wong, Charlene A, et al.
Publicado: (2015) -
Geographic Accessibility of COVID-19 Test to Treat Sites by Race, Ethnicity, Age, and Rurality
por: Khazanchi, Rohan, et al.
Publicado: (2022)